Progress in Pediatric Cardiology
Volume 24, Issue 1 , Pages 35-46, November 2007

Cardiomyopathy in neuromuscular disorders

  • Lisa M. Dellefave
  • ,
  • Elizabeth M. McNally

      Affiliations

    • Corresponding Author InformationCorresponding author. The University of Chicago 5841 S. Maryland Avenue MC6088 Chicago, IL 60637, United States. Tel.: +1 773 702 2672; fax: +1 773 702 2681.

Department of Medicine, Section of Cardiology and Department of Human Genetics, The University of Chicago, United States

Abstract 

Many neuromuscular disorders affect more than skeletal muscle. Because of the common structural and now more apparent molecular features between skeletal and cardiac muscles, many of the neuromuscular disorders also result in cardiovascular complications. Cardiomyopathy and conduction system diseases are the most frequent extramuscular features seen with many muscular dystrophies. The most common pediatric neuromuscular diseases with cardiac involvement will be discussed, including Duchenne muscular dystrophy, the sarcoglycanopathies, the laminopathies, Friedreich ataxia and Myotonic dystrophy. Although different molecular mechanisms lead to cardiac and skeletal muscle dysfunction in each of these disorders, the primary cardiac consequences include arrhythmias and cardiomyopathy that may or may not lead to congestive heart failure. As different experimental therapies are moving into clinical trials, the effect on the cardiac aspects of disease must be considered. Similarly, as treatments for cardiomyopathy are being tested, the effects on skeletal muscle must be determined.

Abbreviations: ACE, angiotensin converting enzyme, ARB, angiotensin receptor blocker, BMD, Becker Muscular Dystrophy, DMD, Duchenne Muscular Dystrophy, EDMD, Emery Dreifuss Muscular Dystrophy, FKRP, fukutin related protein, LGMD, limb girdle muscular dystrophy, XLDCM, X-linked dilated cardiomyopathy.

Keywords: Muscular dystrophy, Myotonic dystrophy, Cardiomyopathy, Arrhythmia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Grant support: Muscular Dystrophy Association, Doris Duke Charitable Foundation, NIH.

PII: S1058-9813(07)00079-3

doi:10.1016/j.ppedcard.2007.08.005

Progress in Pediatric Cardiology
Volume 24, Issue 1 , Pages 35-46, November 2007